LOGIN
Clinical benefit of Hylan GF-20 over conventional therapy at similar cost in knee OA
January 2016
Clinical benefit of Hylan GF-20 over conventional therapy at similar cost in knee OA
Study Type:Therapy
OE Level Evidence:2
Journal Level of Evidence:N/A
Prospective randomized study comparing the medicoeconomic benefits of Hylan GF-20 vs. conventional treatment in knee osteoarthritis
Joint Bone Spine. 2003 Aug;70(4):276-81Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here
Synopsis
506 patients with knee osteoarthritis and failed response to pharmacological intervention were randomized to receive either three weekly intra-articular injections of Hylan G-F 20 (Synvisc) or conventional therapy. The purpose of the study was to compare the clinical efficacy of the two treatment regimens over a span of 9 months, as well as to evaluate economic factors associated with Hylan G-F 20...
To view the full content, login to your account,
or start your 30-day FREE Trial today.
FREE TRIAL
LOGIN
Forgot Password?
Explore some of our unlocked ACE Reports below!
Learn about our AI Driven
High Impact Search Feature
Our AI driven High Impact metric calculates the impact an article will have by considering both the publishing journal and the content of the article itself. Built using the latest advances in natural language processing, OE High Impact predicts an article’s future number of citations better than impact factor alone.
Continue
Join the Conversation
Please Login or Join to leave comments.